Syra Health Corp. (SYRA) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Syra Health Corp. (SYRA:NASDAQ), powered by AI.

Current Price
$0.24
P/E Ratio
-0.5
Market Cap
2M
Sector
Healthcare
What is the Syra Health Corp. stock price forecast?

Syra Health Corp. is currently trading at $0.24. View real-time AI analysis on Alpha Lenz.

What is Syra Health Corp. insider trading activity?

View the latest insider trading data for Syra Health Corp. on Alpha Lenz.

What is Syra Health Corp.'s P/E ratio?

Syra Health Corp.'s P/E ratio is -0.5.

Syra Health Corp.

$0.24
NASDAQSYRA
Ask about Syra Health Corp.'s future dividend policy...
Alpha Chat Insight

Syra Health Corp. trades at a P/E of -0.5 (undervalued) with modest ROE of -109.1%. 3Y revenue CAGR of 78.2% highlights clear growth momentum.

Ask for details

Company Overview

Syra Health Corp. is a specialized company operating in the healthcare services sector. It primarily focuses on providing comprehensive solutions that aim to enhance healthcare delivery and patient outcomes. The company offers a diverse range of services, including health literacy programs, telemedicine solutions, and healthcare staffing services, catering to the evolving needs of the healthcare industry. Additionally, Syra Health Corp. places a strong emphasis on leveraging technology to improve efficiency and accessibility in healthcare settings, impacting both urban and remote areas. By addressing crucial health education and service delivery challenges, the company plays a significant role in shaping the future of healthcare services. As healthcare continues to be a pivotal industry globally, Syra Health Corp.'s contributions assist in bridging gaps within the system, ultimately supporting the industry’s shift towards more patient-centered and efficient care models.

CEOMs. Priya Prasad
SectorHealthcare
IndustryMedical Care Facilities
Employees57

Company Statistics

(FY 2024)

Profile

Market Cap$1.80M
Revenue$7.98M
Shares Out0.00
Employees57

Margins

Gross20.71%
EBITDA-46.11%
Operating-47.17%
Pre-Tax-47.10%
Net-47.10%

Valuation

P/E-0.48
P/B0.63
EV/Sales0.23
EV/EBITDA0.04
P/FCF-0.61

Growth (CAGR)

Rev 3Yr78.22%
Rev 5YrN/A
Op Inc 3YrN/A
Op Inc 5YrN/A
Net Inc 3YrN/A
Net Inc 5YrN/A

Returns

ROA-87.41%
ROE-109.09%
ROIC-87.03%

Financial Health

Cash & Cash Equivalents$2.40M
Net Debt$-1.59M
Debt/Equity27.82%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
Syra Health Corp. (Healthcare) Stock Forecast & Analysis $0.24 | Alpha Lenz